| Symbol |
Name |
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ARHGAP24
|
Rho GTPase activating protein 24
|
|
ATF2
|
activating transcription factor 2
|
|
ATM
|
ATM serine/threonine kinase
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
CALD1
|
caldesmon 1
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRYAB
|
crystallin, alpha B
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CTBP2
|
C-terminal binding protein 2
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DLG4
|
discs, large homolog 4 (Drosophila)
|
|
EEF2
|
eukaryotic translation elongation factor 2
|
|
EEF2K
|
eukaryotic elongation factor 2 kinase
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
EP300
|
E1A binding protein p300
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
EZR
|
ezrin
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FPR1
|
formyl peptide receptor 1
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GATA4
|
GATA binding protein 4
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GYS1
|
glycogen synthase 1 (muscle)
|
|
H2AFX
|
H2A histone family, member X
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HNRNPA0
|
heterogeneous nuclear ribonucleoprotein A0
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
JUN
|
jun proto-oncogene
|
|
KRT8
|
keratin 8, type II
|
|
LIMK1
|
LIM domain kinase 1
|
|
LIMK2
|
LIM domain kinase 2
|
|
LSP1
|
lymphocyte-specific protein 1
|
|
MAOA
|
monoamine oxidase A
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MKNK2
|
MAP kinase interacting serine/threonine kinase 2
|
|
MSN
|
moesin
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYL12B
|
myosin, light chain 12B, regulatory
|
|
MYL9
|
myosin, light chain 9, regulatory
|
|
NACC1
|
nucleus accumbens associated 1, BEN and BTB (POZ) domain containing
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
OSMR
|
oncostatin M receptor
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PFN1
|
profilin 1
|
|
PGR
|
progesterone receptor
|
|
PKN1
|
protein kinase N1
|
|
PKN2
|
protein kinase N2
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PXN
|
paxillin
|
|
RDX
|
radixin
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
|
SCN8A
|
sodium channel, voltage gated, type VIII alpha subunit
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STMN1
|
stathmin 1
|
|
SYK
|
spleen tyrosine kinase
|
|
TAB1
|
TGF-beta activated kinase 1/MAP3K7 binding protein 1
|
|
TP53
|
tumor protein p53
|
|
TSC2
|
tuberous sclerosis 2
|
|
VIM
|
vimentin
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|